Table 1.
Demographic and Clinical Characteristics of Study Population.
| Number of patients (n) | 69 |
| Median age (y) | 70 (range, 10–95) |
| Gender (%) | |
| Female | 40.58% |
| Male | 59.42% |
| Past Medical History (%) | |
| Diabetes | 62.32% |
| Immunosuppressed state | 4.35% |
| IVDA history | 2.90% |
| Systemic surgery | 2.90% |
| Eye-Specific Characteristics at Presentation (%) | |
| Unilateral | 100% |
| Right eye affected | 55.07% |
| Left eye affected | 44.93% |
| Visual Acuity at Presentation (%) | |
| NLP | 24.64% |
| LP | 27.54% |
| HM | 21.74% |
| CF or more | 21.74% |
| Unable to assess | 4.35% |
| Etiology (%) | |
| Postsurgical | 37.68% |
| Exogenous | 33.33% |
| Post-traumatic | 14.49% |
| Endogenous | 13.04% |
| Unknown etiology | 1.45% |
| Presence of panophthalmitis (%) | |
| Panophthalmitis | 20.29% |
| Outcome (%) | |
| Evisceration or enucleation | 46.38% |
| Eye conservation | 53.62% |
IVDA: intravenous drug abuse; OD: right eye; OS: left eye; NLP: no light perception; LP: light perception; HM: hand motion; CF: counting fingers.